AANA Journal Course: Ketamine and Treatment-Resistant Depression

Availability: In stock


Quick Overview

General Price: $50.00

Associate Member (Student) Price: $21.00

Members Price: $35.00

1.0 Class A Credit

1.0 CE Credit in Pharmacology/Therapeutics

Course Expiration Date: 10/17/2022

Discuss the role of ketamine in alleviating treatment-resistant depression.


Overview of Course

The purpose of this activity is to identify patients with treatment-resistant depression.  Patients who suffer from treatment-resistant depression will be offered a trial of ketamine therapy.

Learner Outcomes

Upon completion of this course, the learner will be able to: 

  1. Discuss the role of ketamine in alleviating treatment-resistant depression.

Verification of Participation

The participant will have only 2 opportunities to successfully complete the course post-test, which is comprised of 5 random questions pulled from the test pool of questions. The passing score of at least 80% is required for the exam in this course. If the participant fails the post test, he or she will not receive CE credits for this course.

Accreditation Statement

This course has been prior approved by the AANA for 1.0 Class A CE credit; AANA Code Number: 1038336.

AANA designates this program as meeting the criteria for up to 1.00 CE Credit in Pharmacology/Therapeutics. 

Course Expiration Date: 10/17/2022

The American Association of Nurse Anesthetists is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

AANA is an approved provider by the California Board of Registered Nursing, CEP #10862.